315 related articles for article (PubMed ID: 16161395)
21. Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: Clinical and radiographic study.
Carti O; Oznurhan F
Niger J Clin Pract; 2017 Dec; 20(12):1604-1609. PubMed ID: 29378994
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial of mineral trioxide aggregate cements in primary tooth pulpotomies.
Celik B; Ataç AS; Cehreli ZC; Uysal S
J Dent Child (Chic); 2013; 80(3):126-32. PubMed ID: 24351693
[TBL] [Abstract][Full Text] [Related]
23. Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars.
Juneja P; Kulkarni S
Eur Arch Paediatr Dent; 2017 Aug; 18(4):271-278. PubMed ID: 28780718
[TBL] [Abstract][Full Text] [Related]
24. A Comparison of four pulpotomy techniques in primary molars: a long-term follow-up.
Sonmez D; Sari S; Cetinbaş T
J Endod; 2008 Aug; 34(8):950-5. PubMed ID: 18634926
[TBL] [Abstract][Full Text] [Related]
25. Pulp treatment for extensive decay in primary teeth.
Smaïl-Faugeron V; Courson F; Durieux P; Muller-Bolla M; Glenny AM; Fron Chabouis H
Cochrane Database Syst Rev; 2014 Aug; (8):CD003220. PubMed ID: 25099759
[TBL] [Abstract][Full Text] [Related]
26. Pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial.
Sakai VT; Moretti AB; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
Br Dent J; 2009 Aug; 207(3):E5; discussion 128-9. PubMed ID: 19629145
[TBL] [Abstract][Full Text] [Related]
27. Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy.
Doyle TL; Casas MJ; Kenny DJ; Judd PL
Pediatr Dent; 2010; 32(1):41-7. PubMed ID: 20298652
[TBL] [Abstract][Full Text] [Related]
28. Clinical and radiographic comparison of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in primary molars.
Patidar S; Kalra N; Khatri A; Tyagi R
J Indian Soc Pedod Prev Dent; 2017; 35(4):367-373. PubMed ID: 28914251
[TBL] [Abstract][Full Text] [Related]
29. Clinical study of Mineral Trioxide Aggregate in primary molars. Comparison between Grey and White MTA--a long term follow-up (84 months).
Cardoso-Silva C; Barbería E; Maroto M; García-Godoy F
J Dent; 2011 Feb; 39(2):187-93. PubMed ID: 21144878
[TBL] [Abstract][Full Text] [Related]
30. A prospective clinical study of mineral trioxide aggregate for partial pulpotomy in cariously exposed permanent teeth.
Barrieshi-Nusair KM; Qudeimat MA
J Endod; 2006 Aug; 32(8):731-5. PubMed ID: 16861071
[TBL] [Abstract][Full Text] [Related]
31. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
[TBL] [Abstract][Full Text] [Related]
32. Dentin bridge formation after white mineral trioxide aggregate (white MTA) pulpotomies in primary molars.
Maroto M; Barbería E; Vera V; García-Godoy F
Am J Dent; 2006 Apr; 19(2):75-9. PubMed ID: 16764128
[TBL] [Abstract][Full Text] [Related]
33. Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation.
Sushynski JM; Zealand CM; Botero TM; Boynton JR; Majewski RF; Shelburne CE; Hu JC
Pediatr Dent; 2012; 34(5):120-8. PubMed ID: 23211896
[TBL] [Abstract][Full Text] [Related]
34. Comparison between calcium hydroxide mixtures and mineral trioxide aggregate in primary teeth pulpotomy: a randomized controlled trial.
Silva LLCE; Cosme-Silva L; Sakai VT; Lopes CS; Silveira APPD; Moretti Neto RT; Gomes-Filho JE; Oliveira TM; Moretti ABDS
J Appl Oral Sci; 2019 May; 27():e20180030. PubMed ID: 31116277
[TBL] [Abstract][Full Text] [Related]
35. Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study.
Naik S; Hegde AH
J Indian Soc Pedod Prev Dent; 2005 Mar; 23(1):13-6. PubMed ID: 15858300
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in permanent teeth with incomplete root development: a randomized controlled trial.
Keswani D; Pandey RK; Ansari A; Gupta S
J Endod; 2014 May; 40(5):599-605. PubMed ID: 24767550
[TBL] [Abstract][Full Text] [Related]
37. The effect of sodium hypochlorite application on the success of calcium hydroxide and mineral trioxide aggregate pulpotomies in primary teeth.
Akcay M; Sari S
Pediatr Dent; 2014; 36(4):316-21. PubMed ID: 25197997
[TBL] [Abstract][Full Text] [Related]
38. Clinical and radiographic evaluation of white MTA versus formocresol pulpotomy: A 48-month follow-up study.
Biedma Perea M; Solano Mendoza B; Garcia-Godoy F; Mendoza Mendoza A; Iglesias-Linares A
Am J Dent; 2017 Jun; 30(3):131-136. PubMed ID: 29178757
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacy of medicaments or techniques for pulpotomy of primary molars: a network meta-analysis.
Guo J; Zhang N; Cheng Y
Clin Oral Investig; 2023 Jan; 27(1):91-104. PubMed ID: 36580161
[TBL] [Abstract][Full Text] [Related]
40. MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta-analysis.
Asgary S; Shirvani A; Fazlyab M
J Clin Pediatr Dent; 2014; 39(1):1-8. PubMed ID: 25631717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
